Stock prices for embryonic stem cell research companies took a hit when the U.S. Senate failed to pass a bill to overturn President Bush’s stem cell funding policy by a veto proof margin. Worcester, MA’s, Advanced Cell Technology—which opened an office in California to try and take advantage of the cornicopia of Proposition 71 money—lost value, as did California’s Geron. Some adult stem cell companies also lost ground, but others gained.
Well, the market doesn’t lie: A big part of the drive to overturn Bush’s policy is pure corporate welfare pork. Sooweeee!
YOU MIGHT ALSO LIKE
The Dreadful Christ of Pär Lagerkvist
It’s dangerous to meet a god,” says the disgraced Pythia in Pär Lagerkvist’s The Sibyl. Her observation…
The Possibility of Possibility
"Might could” is a Southern expression meaning “maybe I could” or “I might be able to,” conveying…
The False Promise of No Contact
Around the time nineteen-year-old Alice began cutting ties with her family, she announced on social media that…
